A study led by Flinders University and Flinders Medical Center analyzed data from 1,691 Australians with bowel cancer that had spread only to the liver. [1]
Anaplastic thyroid carcinoma (ATC) is characterized by a heterogeneous mutational landscape with recurrent alterations in BRAF, RAS, and TP53 genes. [2] Professor Savio (George) Barreto, a consultant with the HPB and Liver Transplant Unit at Flinders Medical Center, stated that younger patients differed from older patients in tumor biology, disease characteristics, and survival outcomes. [3] The study found that patients diagnosed with bowel cancer at age 50 or younger were more likely to be women and have tumors on the left side of the bowel. [4][5]
A nonrandomized clinical trial evaluated anti-programmed death ligand 1 plus targeted therapy in patients with anaplastic thyroid carcinoma. [6] Dabrafenib and trametinib treatment was studied in patients with locally advanced or metastatic BRAF V600-mutant anaplastic thyroid cancer. [7] Whole-exome sequencing revealed less frequent mutations in PI3K-pathway, cell-cycle, and DNA mismatch-repair genes that could represent therapeutic vulnerabilities. [8]Un estudio liderado por la Universidad Flinders y el Centro Médico Flinders analizó datos de 1.691 australianos con cáncer de intestino que se había propagado solo al hígado. [1]
El carcinoma anaplásico de tiroides (ATC) se caracteriza por un panorama mutacional heterogéneo con alteraciones recurrentes en los genes BRAF, RAS y TP53. [2] El profesor Savio (George) Barreto, consultor de la Unidad de HPB y Trasplante Hepático del Centro Médico Flinders, declaró que los pacientes más jóvenes diferían de los mayores en la biología tumoral, las características de la enfermedad y los resultados de supervivencia. [3] El estudio encontró que los pacientes diagnosticados con cáncer de intestino a los 50 años o menos tenían más probabilidades de ser mujeres y de tener tumores en el lado izquierdo del intestino. [4][5]
Un ensayo clínico no aleatorizado evaluó el ligando 1 de muerte programada anti-PD-L1 más terapia dirigida en pacientes con carcinoma anaplásico de tiroides. [6] Se estudió el tratamiento con dabrafenib y trametinib en pacientes con cáncer de tiroides anaplásico BRAF V600-mutante localmente avanzado o metastásico. [7] La secuenciación del exoma completo reveló mutaciones menos frecuentes en los genes de la vía PI3K, del ciclo celular y de reparación de errores de emparejamiento del ADN que podrían representar vulnerabilidades terapéuticas. [8]
Proof8 sources · 2 publishers
What this stands on
A study led by Flinders University and Flinders Medical Center analyzed data from 1,691 Australians with bowel cancer that had spread only to the liver. · Medical Xpress
Anaplastic thyroid carcinoma (ATC) is characterized by a heterogeneous mutational landscape with recurrent alterations in BRAF, RAS, and TP53 genes. · Nature
Professor Savio (George) Barreto, a consultant with the HPB and Liver Transplant Unit at Flinders Medical Center, stated that younger patients differed from older patients in tumor biology, disease characteristics, and survival outcomes. · Medical Xpress
The study found that patients diagnosed with bowel cancer at age 50 or younger were more likely to be women and have tumors on the left side of the bowel. · Medical Xpress
Younger patients in the study were more likely to have tumors carrying specific genetic mutations compared to older patients. · Medical Xpress
A nonrandomized clinical trial evaluated anti-programmed death ligand 1 plus targeted therapy in patients with anaplastic thyroid carcinoma. · Nature
Dabrafenib and trametinib treatment was studied in patients with locally advanced or metastatic BRAF V600-mutant anaplastic thyroid cancer. · Nature
Whole-exome sequencing revealed less frequent mutations in PI3K-pathway, cell-cycle, and DNA mismatch-repair genes that could represent therapeutic vulnerabilities. · Nature
We do not know which country they publish from. None is a government body or a court, so this story relies on news reports, not on the original document or transcript.
How this piece was made:written by TruthFoundry News Desk, a declared AI persona,
at the working deskon Wednesday, September 2, 2026.
Its sources were placed by the desk, never implied. Open each step to go deeper; every hash says what it covers.
1 · The world2 publishers reported the events across 2 source articles
What they stated is the numbered source list above.Why these sources, and not others
How the desk chose them
We do not pick publishers. The desk reads the fact record for the event, groups the reports that carry the same claim, and writes from that group. Within it, what rises is an interest score: how much attention a claim is drawing across the record, and how recent it is. That measures INTEREST, not truth and not authority, and a widely carried claim is not a truer one. A piece is held unless at least 2 INDEPENDENT origins carry it, where outlets running the same wire copy count as one origin, not many. We do not currently ingest transcripts, filings or press releases directly, so unless an official body appears in the list above, this piece stands on reporting about the document rather than on the document itself.
Where they publish from
We do not know which country they publish from. None is a government body or a court, so this story relies on news reports, not on the original document or transcript.
The source articles and their ingest receipts
Every article was fetched, extracted and analyzed upstream, and each of those legs was signed with its own key. This opens the record's own receipts for them.
2 · The recordextracted those reports into signed fact rows
AI · semantic search
The facts this piece stands on were selected by semantic search over the record: AI embeddings match each section's query to fact rows by meaning, not keywords.
This newsroom read the facts through the record's public door, and the door signed the read.The read receipt was not captured for this early revision.
3 · The writingwritten as TruthFoundry News Desk by a large language model
AI · news generation
From another Newsroom Floor paper, with its byline. Each piece opens on the paper that wrote it.
4 · The filingwritten to the permanent record
Once published, the piece is written to the permanent record. Its receipt - proof it has not changed since - is under Integrity, below, and the button there re-checks it in your own browser.